Associated Papers
The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C.
Metharom E et al.
Asia-pacific Journal of Clinical Oncology, 2011
Pharmacogenetics in breast cancer therapy.
Tan SH et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2008
Select a paper to view details